Ads
related to: what happened to dristan tablets
Search results
Results From The WOW.Com Content Network
Dristan 12-Hour Nasal Spray is a nasal decongestant, the active ingredient of which is oxymetazoline hydrochloride 0.05%. [1] Dristan Cold Multi-Symptom Tablets contain three active ingredients: acetaminophen , USP 325 mg (a pain reliever and fever reducer ), chlorpheniramine maleate , USP 2 mg (an antihistamine ), and phenylephrine HCl , USP 5 ...
The Dristan inhaler has since been discontinued. Furthermore, Wyeth was acquired by Pfizer in 2009. All products currently sold under the Dristan brand are manufactured by Foundation Consumer Brands; Foundation Consumer Brands acquired the Dristan brand in 2020. [75] Foundation Consumer Brands is itself owned by Kelso & Company.
The original formula for Actifed contained pseudoephedrine hydrochloride 60 mg as the nasal decongestant and triprolidine hydrochloride 2.5 mg as the antihistamine. . However, in response to widespread laws requiring products containing pseudoephedrine to be kept behind the pharmacy counter, Pfizer changed Actifed's U.S. formula in late 2006 to contain phenylephrine HCl 10 mg as the nasal ...
Dexamyl (or Drinamyl in the UK) was the brand name of a combination drug composed of amobarbital (previously called amylbarbitone) and dextroamphetamine (Dexedrine) within the same pill.
It is taken orally, most commonly as an antidepressant, often in an extended-release tablet form. Duloxetine is also used to treat some forms of pain and works by increasing neurotransmitters in ...
Novo Nordisk CEO Lars Fruergaard Joergensen in December during a presentation of a new production site. The company's latest attempt at a weight loss drug, CagriSema, matched the bar set by a ...
Eli Lilly’s weight loss drug Zepbound is no longer in short supply, the FDA said, worrying patients who use cheaper, off-brand versions of the drug. On Thursday, Dec. 19, the U.S. Food and Drug ...
“We always were concerned about heroin,” said Kevin Sabet, a former senior drug policy official in the Obama administration. “We were always cognizant of the push-down, pop-up problem. But we weren’t about to let these pill mills flourish in the name of worrying about something that hadn’t happened yet. …